Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy NovaBay Pharmaceuticals stock
Learn how to easily invest in NovaBay Pharmaceuticals stock.
NovaBay Pharmaceuticals Inc is a biotechnology business based in the US. NovaBay Pharmaceuticals shares (NBY) are listed on the NYSE MKT and all prices are listed in US Dollars. NovaBay Pharmaceuticals employs 22 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in NovaBay Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NBY – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
NovaBay Pharmaceuticals stock price (NYSE MKT: NBY)Use our graph to track the performance of NBY stocks over time.
NovaBay Pharmaceuticals shares at a glance
|Latest market close||$0.34|
|52-week range||$0.35 - $1.79|
|50-day moving average||$0.48|
|200-day moving average||$0.62|
|Wall St. target price||$3.10|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.17|
Buy NovaBay Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy NovaBay Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
NovaBay Pharmaceuticals price performance over time
|1 week (2022-01-06)||N/A|
|1 month (2021-12-16)||-24.44%|
|3 months (2021-10-15)||-38.38%|
|6 months (2021-07-16)||-41.38%|
|1 year (2021-01-15)||-62.77%|
|2 years (2020-01-17)||-45.87%|
|3 years (2019-01-17)||1.03|
|5 years (2017-01-17)||3.7|
NovaBay Pharmaceuticals financials
|Revenue TTM||$7.7 million|
|Gross profit TTM||$6 million|
|Return on assets TTM||-31.66%|
|Return on equity TTM||-63.84%|
|Market capitalisation||$16.8 million|
TTM: trailing 12 months
NovaBay Pharmaceuticals share dividends
We're not expecting NovaBay Pharmaceuticals to pay a dividend over the next 12 months.
Have NovaBay Pharmaceuticals's shares ever split?
NovaBay Pharmaceuticals's shares were split on a 1:25 basis on 20 December 2015. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NovaBay Pharmaceuticals shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for NovaBay Pharmaceuticals shares which in turn could have impacted NovaBay Pharmaceuticals's share price.
NovaBay Pharmaceuticals share price volatility
Over the last 12 months, NovaBay Pharmaceuticals's shares have ranged in value from as little as $0.35 up to $1.79. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while NovaBay Pharmaceuticals's is 3.4764. This would suggest that NovaBay Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
NovaBay Pharmaceuticals overview
NovaBay Pharmaceuticals, Inc. , a medical device company, develops products for the eye care markets in the United States and internationally. The company offers Avenova, a solution for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye, including the eyelid; CelleRx Clinical Reset, a gentle and soothing facial spray; and NeutroPhase and PhaseOne for the wound care market. It also offers KN95 Masks. The company sells its products through distribution partners, as well as offers Avenova and CelleRx Clinical Reset through online sales channels. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals in the news
NovaBay Pharmaceuticals Inc. Shares Near 52-Week Low - Market Mover
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Frequently asked questionsWhat percentage of NovaBay Pharmaceuticals is owned by insiders or institutions?
Currently 21.099% of NovaBay Pharmaceuticals shares are held by insiders and 2.651% by institutions. How many people work for NovaBay Pharmaceuticals?
Latest data suggests 22 work at NovaBay Pharmaceuticals. When does the fiscal year end for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals's fiscal year ends in December. Where is NovaBay Pharmaceuticals based?
NovaBay Pharmaceuticals's address is: 2000 Powell Street, EmeryVille, CA, United States, 94608 What is NovaBay Pharmaceuticals's ISIN number?
NovaBay Pharmaceuticals's international securities identification number is: US66987P2011 What is NovaBay Pharmaceuticals's CUSIP number?
NovaBay Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 628729105
More guides on Finder
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Can Turo’s IPO do better than Uber and Airbnb?
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
Ask an Expert